Fresenius Medical Care AG (FMS) Common Equity (2016 - 2024)
Historic Common Equity for Fresenius Medical Care AG (FMS) over the last 16 years, with Q4 2024 value amounting to $16.9 billion.
- Fresenius Medical Care AG's Common Equity rose 562.73% to $16.9 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $16.9 billion, marking a year-over-year increase of 562.73%. This contributed to the annual value of $16.9 billion for FY2024, which is 562.73% up from last year.
- According to the latest figures from Q4 2024, Fresenius Medical Care AG's Common Equity is $16.9 billion, which was up 562.73% from $16.0 billion recorded in Q4 2023.
- Fresenius Medical Care AG's 5-year Common Equity high stood at $16.9 billion for Q4 2024, and its period low was $14.7 billion during Q4 2020.
- In the last 5 years, Fresenius Medical Care AG's Common Equity had a median value of $16.0 billion in 2023 and averaged $15.9 billion.
- Per our database at Business Quant, Fresenius Medical Care AG's Common Equity soared by 876.8% in 2021 and then tumbled by 143.59% in 2022.
- Quarter analysis of 5 years shows Fresenius Medical Care AG's Common Equity stood at $14.7 billion in 2020, then increased by 8.77% to $16.0 billion in 2021, then dropped by 1.44% to $15.8 billion in 2022, then increased by 1.21% to $16.0 billion in 2023, then increased by 5.63% to $16.9 billion in 2024.
- Its Common Equity stands at $16.9 billion for Q4 2024, versus $16.0 billion for Q4 2023 and $15.8 billion for Q4 2022.